# The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.

> **NCT03353610** · — · TERMINATED · sponsor: **Milestone Pharmaceuticals Inc.** · enrollment: 354 (actual)

## Conditions studied

- Paroxysmal Supraventricular Tachycardia (PSVT)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03353610
- **Lead sponsor:** Milestone Pharmaceuticals Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-16
- **Primary completion:** 2020-03-16
- **Final completion:** 2020-03-16
- **Target enrollment:** 354 (ACTUAL)
- **Why stopped:** Termination due to lack of adequate enrollment
- **Last updated:** 2020-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03353610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03353610, "The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03353610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*